FDA Adverse Event Malfunction Summary report: N

DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM

MDR report key: 6551543 · Received May 8, 2017

Report

Report Number
3004753838-2017-40229
Event Type
Malfunction
Date Received
May 8, 2017
Date of Event
April 16, 2017
Report Date
April 16, 2017
Manufacturer
DEXCOM, INC.
Product Code
PQF
UDI-DI
30386270000270
PMA / PMN Number
P120005
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4).

Additional Manufacturer Narrative · 1

(B)(4). THE G5 SYSTEM IS ASSOCIATED WITH PRODUCT CODE PQF.

Description of Event or Problem · 1

THE COMPLAINT RECEIVER DEVICE WAS RETURNED FOR EVALUATION. THE DEVICE WAS VISUALLY INSPECTED AND IT PASSED. THE DATA LOG COULD NOT BE RETRIEVED AND FUNCTIONAL TESTING COULD NOT BE PERFORMED BECAUSE OF THE "CALL TECH SUPPORT" ERROR. THE CUSTOMER COMPLAINT COULD NOT BE CONFIRMED BECAUSE IT COULD NOT BE DETERMINED IF A LOSS OF CONNECTION OCCURRED. THE ROOT CAUSE COULD NOT BE DETERMINED. A TRANSMITTER (LOT #6000714, (B)(4)) DEVICE WAS RETURNED FOR EVALUATION. THE DEVICE WAS VISUALLY INSPECTED AND NO DEFECT WAS FOUND. A VOLTAGE TEST WAS PERFORMED AND IT PASSED. A PAIRING TEST WAS PERFORMED AND IT FAILED. FUNCTIONAL TESTING WAS PERFORMED AND THE TEST FAILED. THE REPORTED EVENT OF LOSS OF CONNECTION WAS CONFIRMED. THE ROOT CAUSE WAS DETERMINED TO BE A DEFECTIVE TRANSMITTER.

Description of Event or Problem · 1

DEXCOM WAS MADE AWARE ON (B)(6) 2017 THAT ON (B)(6) 2017, PATIENT EXPERIENCED A LOSS OF CONNECTION BETWEEN THE TRANSMITTER AND RECEIVER. NO ADDITIONAL PATIENT OR EVENT INFORMATION IS AVAILABLE. THE RECEIVER HAS BEEN RECEIVED FOR EVALUATION. A FOLLOW UP REPORT WILL BE SUBMITTED UPON COMPLETION OF DEVICE INVESTIGATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
332980 DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM CONTINUOUS GLUCOSE MONITOR PQF DEXCOM, INC. MT22719-BLU 5210538 30386270000270

Patients

Seq Age Sex Outcome Treatment
1 3 YR